Paloma Partners’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Paloma Partners’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,333	Closed	-$34K	–	1221
2022 Q3	$34K	Hold	3,333	–	–	﹤0.01%	908
2022 Q2	$33K	Hold	3,333	–	–	﹤0.01%	1042
2022 Q1	$33K	Hold	3,333	–	–	﹤0.01%	1686
2021 Q4	$33K	Buy	+3,333	New	+$33K	﹤0.01%	1845

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Paloma Partners's ARCK Position: Q4 2022 in Review

Paloma Partners sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 10,000 shares — an estimated $101K sold.

Paloma Partners first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $101K in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Paloma Partners reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Paloma Partners sold 10,000 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $101K.
Paloma Partners first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Paloma Partners's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $101K in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Paloma Partners's 13F filing for Q4 2022, filed 14 Feb 2023.